Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

36.48 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Corcept Therapeutics Incorporated - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Corcept Appoints Monica Tellado as President, Emerging Markets
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Despite its growth, NASDAQ:CORT remains within the realm of affordability. ↗
Looking for growth without the hefty price tag? Consider NASDAQ:CORT. 
Via Chartmill
News headline image
5 Analysts Have This to Say About Corcept Therapeutics ↗
 
Via Benzinga
News headline image
Expert Ratings for Corcept Therapeutics ↗
 
Via Benzinga
News headline image
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session. Corcept Therapeutics Incorporated (NASDAQ: CORT) shares... 
Via Benzinga
Topics Stocks
News headline image
Why Corcept Therapeutics Stock Popped Today ↗
Corcept Therapeutics Incorporated (NASDAQ: CORT) shares surged Thursday following a second-quarter earnings beat. 
Via Benzinga
News headline image
Earnings Preview For Corcept Therapeutics ↗
 
Via Benzinga
News headline image
S&P 500 Pullback Update: Are We Nearing The Light At The End Of The Tunnel? ↗
Find out at what point can we consider a reversal of the upswing for S&P 500 and the demand and the support zone for short-term movement. 
Via Talk Markets
Topics Stocks
Corcept Therapeutics Inc. (NASDAQ: CORT) Sets New 52-Week High in Wednesday Session
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90... 
Via Benzinga
News headline image
Analyst Expectations for Corcept Therapeutics's Future ↗
 
Via Benzinga
News headline image
Corcept Therapeutics's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Analyst Ratings for Corcept Therapeutics ↗
 
Via Benzinga
News headline image
Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023 ↗
 
Via Benzinga
News headline image
Corcept Therapeutics Announces Final Results of Tender Offer
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Short Volatility Alert: Corcept Therapeutics ↗
On Tuesday, shares of Corcept Therapeutics (NASDAQ: CORT) experienced volatile short activity. After the activity, the stock price went up +1.66% to $22.02. The overall sentiment for CORT has been... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023 ↗
 
Via Benzinga
News headline image
Corcept Therapeutics Announces Preliminary Results of Tender Offer
From Corcept Therapeutics Incorporated
Via GlobeNewswire
News headline image
Corcept Therapeutics Initiates CATALYST Clinical Trial
From Corcept Therapeutics Incorporated
Via GlobeNewswire
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.